Company Overview and News

0
ANZ backs moratorium on drought-stricken farmers, admits to misconduct

2018-07-17 theage.com.au
ANZ Bank has backed a moratorium on the repossession of drought-stricken farms and, along with the Commonwealth Bank, admitted to "misconduct" in their treatment of some rural customers.
NAUBF NAB NASXF NABZY

0
ANZ backs moratorium on drought-stricken farmers, admits to misconduct

2018-07-17 smh.com.au
ANZ Bank has backed a moratorium on the repossession of drought-stricken farms and, along with the Commonwealth Bank, admitted to "misconduct" in their treatment of some rural customers.
NAUBF NAB NASXF NABZY

0
Passive savers hit as banks slice rates on deposits

2018-07-17 smh.com.au
In the past fortnight, Australia's two biggest banks quietly inflicted a much bigger hit on savings account interest rates than they would dare make to mortgage rates.
NAUBF NAB NASXF NABZY

0
Former Perpetual chief to run MLC ahead of NAB divestment

2018-07-17 theage.com.au
Former Perpetual boss Geoff Lloyd will lead National Australia Bank's MLC business, as the big four bank prepares to split its wealth arm from its core banking operations.
NAUBF NAB NASXF NABZY

0
Former Perpetual chief to run MLC ahead of NAB divestment

2018-07-17 smh.com.au
Former Perpetual boss Geoff Lloyd will lead National Australia Bank's MLC business, as the big four bank prepares to split its wealth arm from its core banking operations.
NAUBF NAB NASXF NABZY

0
These Wheat Prices Are Enough to Put Australia Off Bread - Bloomberg

2018-07-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
NAUBF NAB NASXF NABZY

0
Finding it harder to get a loan? Here's why

2018-07-16 abc.net.au
It's harder to get a loan in Australia right now than it has been in years.
NAUBF NAB NASXF NABZY

0
Westpac scraps new property lending to DIY super funds

2018-07-16 theage.com.au
Westpac is pulling the plug on new lending to self-managed superannuation funds (SMSF) for property investment, in the latest move by a major to tighten the flow of money into domestic real estate.
NAUBF NAB NASXF NABZY

0
Westpac scraps new property lending to DIY super funds

2018-07-16 smh.com.au
Westpac is pulling the plug on new lending to self-managed superannuation funds (SMSF) for property investment, in the latest move by a major to tighten the flow of money into domestic real estate.
NAUBF NAB NASXF NABZY

0
Banks ramp up sharing of 'positive' data on customers, despite concerns

2018-07-15 smh.com.au
Banks are on track to address a key "blind spot" in their lending assessments by early next year, as several of the country's biggest lenders finally prepare to engage with a customer data-sharing regime.
NAUBF NAB NASXF NABZY

0
Banks ramp up sharing of 'positive' data on customers, despite concerns

2018-07-15 theage.com.au
Banks are on track to address a key "blind spot" in their lending assessments by early next year, as several of the country's biggest lenders finally prepare to engage with a customer data-sharing regime.
NAUBF NAB NASXF NABZY

0
Australia’s new housing hot spot

2018-07-12 ntnews.com.au
QUEENSLAND’S housing market is tipped to lead the country for capital growth in the next two years while prices in NSW and Victoria continue to slide, according to a survey of hundreds of property professionals.
NAUBF NAB NASXF NABZY

0
Crime has no impact on property prices in Melbourne: report

2018-07-12 smh.com.au
Crime in Melbourne has no impact on property prices from suburb to suburb, Infrastructure Victoria has found.
NAUBF NAB NASXF NABZY

0
Importers snap up cheap U.S. soybeans as China stops buying

2018-07-12 reuters
CHICAGO (Reuters) - China’s retaliatory tariffs on U.S. soybeans, threatened for weeks and enacted Friday, have driven down prices and triggered a wave of bargain shopping by importers in other countries stocking up on cheap U.S. supplies, according to a Reuters analysis of government data.
NAUBF NAB NASXF BGEPF BG NABZY ADM

0
Flash - Asian markets tumble as new tariffs threat ends calm - France 24

2018-07-11 france24
The uneasy calm that had descended on Asian markets was shattered Wednesday after the US threatened to hammer China with tariffs on a further $200 billion of imports, ratcheting up a trade war between the world's top two economies.
NAUBF NAB NASXF NABZY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 632525408